To test MEZ-XRF on physiologically relevant samples, we imaged biopsy core punches from a HER2+ tumor, a luminal A tumor and a luminal B HER2− tumor after staining for key breast cancer diagnostic markers as well as for epithelial, stromal and immune markers (Fig. 3a). This evidence concerns the gene ERBB2 and breast carcinoma.